Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know (Q35852348)

10 August 2017

1 reference

title

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know (English)

1 reference

10 August 2017

Giuseppe Pantaleo

1 reference

10 August 2017

Richard A Koup

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

806-810

1 reference

Poxviruses and immune evasion

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Immune responses to varicella-zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Tissue xenografts as a model system for study of the pathogenesis of papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Kinetics of the immune response during HBV and HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Dissecting the host response to a gamma-herpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

The Evolution of Antigen-Specific CD8+T Cell Responses after Natural Primary Infection of Humans with Epstein-Barr Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Skewed maturation of memory HIV-specific CD8 T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Immune control of HIV-1 after early treatment of acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Defining the Protective Antibody Response for HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Antibody neutralization and escape by HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Public health. AIDS vaccine trial produces disappointment and confusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

A role for carbohydrates in immune evasion in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

HIV preferentially infects HIV-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

7 January 2021

Dynamics of T cell responses in HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

7 January 2021

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

7 January 2021

Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FNM0804-806

7 January 2021

Identifiers

DOI

10.1038/NM0804-806

1 reference

10 August 2017

1 reference